J9263 Oxaliplatin
Also known as: oxaliplatin, Eloxatin
Injection of oxaliplatin, a platinum-based chemotherapy agent. An alkylating agent used for colorectal cancer and other malignancies.
In Plain Language
platinum cancer injection; colorectal cancer drug
Clinical Context
First-line therapy for metastatic colorectal cancer, often used in FOLFOX regimen combinations. Also used for gastric and ovarian cancers in select patients.
RVU Information
CPT J9263 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9263?
CPT J9263 (Oxaliplatin) is a J Codes (Drugs) code. Injection of oxaliplatin, a platinum-based chemotherapy agent. An alkylating agent used for colorectal cancer and other malignancies.
How is J9263 administered?
CPT J9263 is administered by a healthcare provider, typically via injection or infusion. First-line therapy for metastatic colorectal cancer, often used in FOLFOX regimen combinations. Also used for gastric and ovarian cancers in select patients. It is used by Oncology, Gastroenterology, Surgery.
When is CPT J9263 used?
First-line therapy for metastatic colorectal cancer, often used in FOLFOX regimen combinations. Also used for gastric and ovarian cancers in select patients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.